ConductScience.org, home

Paper36948331

Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease.

Pradhan B and 1 other. Int J Biol Macromol, 2023. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease. Papers, record 36948331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36948331

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Biological activity of algal derived carrageenan: A comprehensive review in light of human health and disease.
PubMed
Journal
Int J Biol Macromol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
9.47
iCite
Revised in PubMed
2023-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pradhan BBiswajita
2Ki JSJang-Seu

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SeaweedMajor topic
Humans
Carrageenan
Polysaccharides
Plants
Antioxidants

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42787751Seaweed sulfated polysaccharides regulate the gut microbiota-mucosal barrier-innate immunity axis: structural heterogeneity, immunological evidence, and translational prospects.Front Immunol2026https://conductscience.org/library/papers/42787751PubMed
42560937Carrageenan: Food Additive or Health Concern? A Comprehensive Review.Ann Nutr Metab2026https://conductscience.org/library/papers/42560937PubMed
42431984Extraction, characterization, and antimicrobial potential of Kappa-Carrageenan from Kappaphycus alvarezii with HasA-targeted molecular docking validation.NPJ Sci Food2026https://conductscience.org/library/papers/42431984PubMed
41568226Ammonia-triggered disintegration of kappa-carrageenan hydrogel carrier for site-specific anti-inflammatory drug delivery.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/41568226PubMed
41295412Botryocladia leptopoda Extracts Promote Wound Healing Ability via Antioxidant and Anti-Inflammatory Activities and Regulation of MMP/TIMP Expression.Mar Drugs2025https://conductscience.org/library/papers/41295412PubMed
41012518Liposomal Encapsulation of Pine Green Cone Essential Oil: The Influence of the Carrier on the Enhancement of Anti-Inflammatory Activity.Pharmaceutics2025https://conductscience.org/library/papers/41012518PubMed
40854650Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris.J Genet Eng Biotechnol2025https://conductscience.org/library/papers/40854650PubMed
40647761Polysaccharide-Based Nanocarriers for Natural Antimicrobials: A Review.Polymers (Basel)2025https://conductscience.org/library/papers/40647761PubMed
40584756Carrageenan: structure, properties and applications with special emphasis on food science.RSC Adv2025https://conductscience.org/library/papers/40584756PubMed
40072612The biotechnological and economic potential of macroalgae in the Baltic Sea.Planta2025https://conductscience.org/library/papers/40072612PubMed
39997715Exploring the Antineoplastic Properties of the Lebanese Jania rubens Against Colorectal Cancer.Metabolites2025https://conductscience.org/library/papers/39997715PubMed
39958265Sustainable and biocompatible hybrid materials-based sulfated polysaccharides for biomedical applications: a review.RSC Adv2025https://conductscience.org/library/papers/39958265PubMed
39678953Algae a Potential Source in Cosmetics: Current Status, Challenges, and Economic Implications.Indian J Microbiol2024https://conductscience.org/library/papers/39678953PubMed
39330232Healing Potential of the Marine Polysaccharides Carrageenan and Ulvan on Second-Degree Burns.J Funct Biomater2024https://conductscience.org/library/papers/39330232PubMed
39195465Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review.Mar Drugs2024https://conductscience.org/library/papers/39195465PubMed
39066021Piezoelectric Behaviour in Biodegradable Carrageenan and Iron (III) Oxide Based Sensor.Sensors (Basel)2024https://conductscience.org/library/papers/39066021PubMed
39057449Gelatin-Based Scaffolds with Carrageenan and Chitosan for Soft Tissue Regeneration.Gels2024https://conductscience.org/library/papers/39057449PubMed
38396650Structure, Physicochemical Properties and Biological Activity of Lipopolysaccharide from the Rhizospheric Bacterium Ochrobactrum quorumnocens T1Kr02, Containing d-Fucose Residues.Int J Mol Sci2024https://conductscience.org/library/papers/38396650PubMed
37896072New Perspective for Macroalgae-Based Animal Feeding in the Context of Challenging Sustainable Food Production.Plants (Basel)2023https://conductscience.org/library/papers/37896072PubMed
37504914Algal Phycocolloids: Bioactivities and Pharmaceutical Applications.Mar Drugs2023https://conductscience.org/library/papers/37504914PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36948331

GET https://conductscience.org/api/papers/v1/36948331/cited_by?page=2